The company is the latest to signal intent to enter the increasingly populated market for software-as-a-service (SaaS) clinical trial systems. MedNet believes its electronic data capture (EDC) offering is compelling enough to capture a slice of this market.
"Combining iMedNet's industry-leading technology with its pay-as-you-go, SaaS pricing model will significantly lessen the administrative burden and costs traditionally associated with EDC solutions", explained John Robertson, president and CEO of MedNet.
The cost-benefits are similar to those associated with other SaaS platforms, such as reduced infrastructure expenditure and maintenance, and consequently iMedNet will succeed or fail on the strength of the technology.
iMedNet uses a ‘drag and drop’ interface to allow the user to set up forms, business logic, workflows and protocols using a reusable component library. Adopting this platform can cut the time for study creation and deployment to “a matter of days”, according to MedNet.
Users can access the system through any internet-connected PC. MedNet believes its system is secure, an important factor for contract research organisations (CRO) and pharmas using SaaS.
Study administrators, data managers and monitors, investigators, research coordinators and patients can all be granted access to the system. Currently the system is in beta-testing and will be available for preview at the eClinical Technology Summit in Orlando, Florida, US in April.
iMedNet is currently scheduled for general release in the third quarter of 2010. The system is designed to be used at any stage of clinical trials, from Phase I through to post-marketing.